Wall Street Zen downgraded shares of Nutex Health (NASDAQ:NUTX – Free Report) from a buy rating to a hold rating in a report published on Saturday,Wall Street Zen reports.
NUTX has been the subject of a number of other reports. B. Riley Financial boosted their price objective on shares of Nutex Health from $290.00 to $325.00 and gave the stock a “buy” rating in a research note on Friday. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Lake Street Capital reiterated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. B Riley reissued a “buy” rating on shares of Nutex Health in a research report on Friday. Finally, Zacks Research upgraded shares of Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $317.50.
Get Our Latest Analysis on NUTX
Nutex Health Stock Performance
Nutex Health (NASDAQ:NUTX – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping the consensus estimate of $4.95 by $4.43. The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.
Institutional Investors Weigh In On Nutex Health
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Corient Private Wealth LP raised its stake in Nutex Health by 5.1% during the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock valued at $1,142,000 after purchasing an additional 325 shares during the last quarter. Amundi acquired a new stake in Nutex Health in the 2nd quarter worth $378,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Nutex Health in the 2nd quarter worth $906,000. California State Teachers Retirement System increased its holdings in shares of Nutex Health by 25,615.8% during the 2nd quarter. California State Teachers Retirement System now owns 934,768 shares of the company’s stock worth $159,743,000 after purchasing an additional 931,133 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Nutex Health by 81.9% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,399 shares of the company’s stock worth $752,000 after purchasing an additional 1,980 shares during the period. Institutional investors and hedge funds own 5.32% of the company’s stock.
Nutex Health Company Profile
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Featured Stories
- Five stocks we like better than Nutex Health
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
